Trial intelligence / Profile preview

Liposomal Bupivacaine for Postoperative Quality of Recovery in VATS Partial Pneumonectomy

NCT07512635Phase 4Recruiting

Sponsor
Sanming First Hospital
Start
Apr 2026
Primary completion
Apr 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Sanming First Hospital. Started Apr 2026; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07512635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07512635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call